Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections
The bacillus Calmette–Guérin (BCG) is an attenuated bacterium derived from virulent <i>Mycobacterium bovis</i>. It is the only licensed vaccine used for preventing severe forms of tuberculosis in children. Besides its specific effects against tuberculosis, BCG administration is also asso...
Main Authors: | Ana Carolina V. S. C. de Araujo, Fábio Mambelli, Rodrigo O. Sanches, Fábio V. Marinho, Sergio C. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/12/1386 |
Similar Items
-
Bacillus Calmette–Guérin Immunotherapy for Cancer
by: Fabíola Cardillo, et al.
Published: (2021-05-01) -
Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01) -
Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
by: Maria Carolina Sisco, et al.
Published: (2020-05-01) -
Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations
by: Ekaterini Goudouris, et al.
Published: (2023-03-01) -
Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
by: Mitchell V. Palmer, et al.
Published: (2018-10-01)